header
Image from OpenLibrary

Comparison of levosimendan versus an IABP in patients with poor left ventricular function undergoing coronary artery bypass graft surgery / Mohamed Ahmed Mohamed Allam ; Supervised Ehab Mohamed Elshihy , Amr Mohamed Rouchdy , Alaa Mohamed Omar

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Mohamed Ahmed Mohamed Allam , 2018Description: 79 P. : charts , facsimiles ; 25cmOther title:
  • مقارنة بين استخدام عقار الليفوسيمندان و المضخة البالونية للشريان الاورطي للمرضي الذين يعانون من ضعف بكفاءه عضلة القلب و سوف يجرون عملية ترقيع للشرايين التاجيه [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University -Faculty of Medicine - Department of Cardiothoracic Surgery Summary: Introduction:Many studies have shown the critical complications of CABG in patients with poor contractility. The use of levosimendan versus an IABP in patients with poor left ventricular function undergoing coronary artery bypass graft surgery is controversial;the aim of this study is to compare the use of levosimendan versus an IABP in patients with poor left ventricular function undergoing coronary artery bypass graft surgery. Patients and method:A prospective non randomized study that was conducted on sixty patients presented with coronary insufficiency were subjected to CABG surgery with poor left ventricular function Ejection fraction less than 35% , in kasr el ainy hospitals (Cairo university) from February 2015 to July 2017. The patients were subdivided into two groups 30 in Group (A) will be submitted to levosimendan and Group (B) will be submitted to intra-aortic balloon pumpand were evaluated thoroughly preoperative , intra-operative and postoperative , especially the duration of mechanical ventilation , use of inotropes, Intensive care unit stay, hospital stay and mortality Results:levosimendan infusion group had less significantICUstay thanranging from 3 to 6 days with a mean of 4.4 ± 0.77 day)IABP group (ranging from 4 to 7 days with a mean of 5.2 ± 0.85 day. However, mortality and the frequency of other major complications were no different between our 2 groups
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.05.Ph.D.2018.Mo.C (Browse shelf(Opens below)) Not for loan 01010110076858000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.05.Ph.D.2018.Mo.C (Browse shelf(Opens below)) 76858.CD Not for loan 01020110076858000

Thesis (Ph.D.) - Cairo University -Faculty of Medicine - Department of Cardiothoracic Surgery

Introduction:Many studies have shown the critical complications of CABG in patients with poor contractility. The use of levosimendan versus an IABP in patients with poor left ventricular function undergoing coronary artery bypass graft surgery is controversial;the aim of this study is to compare the use of levosimendan versus an IABP in patients with poor left ventricular function undergoing coronary artery bypass graft surgery. Patients and method:A prospective non randomized study that was conducted on sixty patients presented with coronary insufficiency were subjected to CABG surgery with poor left ventricular function Ejection fraction less than 35% , in kasr el ainy hospitals (Cairo university) from February 2015 to July 2017. The patients were subdivided into two groups 30 in Group (A) will be submitted to levosimendan and Group (B) will be submitted to intra-aortic balloon pumpand were evaluated thoroughly preoperative , intra-operative and postoperative , especially the duration of mechanical ventilation , use of inotropes, Intensive care unit stay, hospital stay and mortality Results:levosimendan infusion group had less significantICUstay thanranging from 3 to 6 days with a mean of 4.4 ± 0.77 day)IABP group (ranging from 4 to 7 days with a mean of 5.2 ± 0.85 day. However, mortality and the frequency of other major complications were no different between our 2 groups

Issued also as CD

There are no comments on this title.

to post a comment.